Jordan
· Delayed Price · Currency is JOD ASE: DADI Company Description
Dar Al Dawa Development and Investment Co. Ltd., an integrated pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical and consumer healthcare products in Levant, Gulf and Yemen, the Middle East, Africa, Europe, and Asia.
It operates through Medicine; and Infants’ Cereals and Milk Formula segments. The company offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, urology, respiratory, gastrointestinal, analgesic and musculoskeletal, central nervous system, gynecology, dermatology, ophthalmology, and oncology; and cereal and milk formula products for infants.
It serves patients and medical communities. Dar Al Dawa Development and Investment Co. Ltd. was incorporated in 1975 and is headquartered in Amman, Jordan.
| Country | Jordan |
| Founded | 1975 |
| Industry | Pharmaceutical Preparations |
| Employees | 1,067 |
| CEO | Khaled Harb |
Contact Details
Address: P.O Box: 9364 Amman, 11191 Jordan | |
| Phone | 962 6222 2200 |
| Website | dadgroup.com |
Stock Details
| Ticker Symbol | DADI |
| Exchange | Amman Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | JOD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Khaled Harb | Chief Executive Officer |
| Shadi Saqfelhait | Chief Financial Officer |
| Mohammed Alsous | Chief Operating Officer |